4//SEC Filing
McKelligon Brian 4
Accession 0001062993-25-004348
CIK 0001711933other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:59 PM ET
Size
6.5 KB
Accession
0001062993-25-004348
Insider Transaction Report
Form 4
McKelligon Brian
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-03-01$1.63/sh−7,550$12,307→ 435,933 total - Tax Payment
Common Stock
2025-03-01$1.63/sh−8,257$13,459→ 427,676 total
Footnotes (2)
- [F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 23, 2023, which vests in four (4) annual equal installments beginning on March 1, 2024 and annually thereafter until fully vested.
- [F2]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 22, 2024, which vests in four (4) annual equal installments beginning on March 1, 2025 and annually thereafter until fully vested.
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857447
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:59 PM ET
- Size
- 6.5 KB